Key result
Transvenous laser-assisted lead extraction yields ~98% clinical success with few major adverse events.
Why the study?
The need for lead extraction has risen alongside increasing cardiovascular implantable electronic device use, requiring evaluation of laser-assisted extraction safety, efficacy, and outcomes.
What are the safety, efficacy, and risk factors associated with transvenous laser-assisted lead extraction in patients with cardiovascular implantable electronic devices?
Cohort (n=1,449)
Yes
What are the safety, efficacy, and risk factors associated with transvenous laser-assisted lead extraction in patients with cardiovascular implantable electronic devices?
Transvenous laser-assisted lead extraction is highly successful with a low procedural complication rate, though mortality is substantially increased in patients with pocket infections, device-related endocarditis, diabetes, or renal insufficiency.
Answers are grounded in this paper and cite their sources.
May support safer lead extraction; leaves open need for prospective confirmation before practice change.
OBJECTIVES: This study sought to examine the safety and efficacy of laser-assisted lead extraction and the indications, outcomes, and risk factors in a large series of consecutive patients. BACKGROUND: The need for lead extraction has been increasing in direct relationship to the increased numbers of cardiovascular implantable electronic devices. METHODS: Consecutive patients undergoing transvenous laser-assisted lead extraction at 13 centers were included. RESULTS: Between January 2004 and December 2007, 1,449 consecutive patients underwent laser-assisted lead extraction of 2,405 leads (20 to 270 procedures/site). Median implantation duration was 82.1 months (0.4 to 356.8 months). Leads were completely removed 96.5% of the time, with a 97.7% clinical success rate whereby clinical goals associated with the indication for lead removal were achieved. Failure to achieve clinical success was associated with body mass index <25 kg/m(2) and low extraction volume centers. Procedural failure was higher in leads implanted for >10 years and when performed in low volume centers. Major adverse events in 20 patients were directly related to the procedure (1.4%) including 4 deaths (0.28%). Major adverse effects were associated with patients with a body mass index <25 kg/m(2). Overall all-cause in-hospital mortality was 1.86%; 4.3% when associated with endocarditis, 7.9% when associated with endocarditis and diabetes, and 12.4% when associated with endocarditis and creatinine > or =2.0. Indicators of all-cause in-hospital mortality were pocket infections, device-related endocarditis, diabetes, and creatinine > or =2.0. CONCLUSIONS: Lead extraction employing laser sheaths is highly successful with a low procedural complication rate. Total mortality is substantially increased with pocket infections or device-related endocarditis, particularly in the setting of diabetes, renal insufficiency, or body mass index <25 kg/m(2). Centers with smaller case volumes tended to have a lower rate of successful extraction.
No takes yet. Share an insight, caveat, or question.
Wazni et al. (2010) conducted a cohort in Cardiovascular implantable electronic device lead extraction (n=1,449). Transvenous laser-assisted lead extraction was evaluated on Clinical success rate. Transvenous laser-assisted lead extraction achieved a 97.7% clinical success rate and 96.5% complete removal rate, with a 1.4% rate of procedure-related major adverse events.
Synapse has enriched 10 related papers. Consider them for comparative context: